Objectives This study was designed to assess the prevalence of adverse drug reactions (ADRs) in the internal medicine wards of two teaching Hospitals, identify the most common ADRs, the principal medications involved, and determine the risk factors implicated in the occurrence of such ADRs. Methods All admissions over 10 weeks were followed prospectively using an intensive drug surveillance method to identify ADRs. Clinical laboratory data, the drug prescribed, and ADRs were taken into consideration. Status of nutrition, liver and kidney function at admission, and ADR time were determined. In order to assess drug interactions a software package was used. Results A total of 405 patients were evaluated, 126 patients (31%) had 128 ADRs, 122 ADRs occurred during hospitalization. Two ADR-related deaths were observed during the study. Reactions affecting the gastrointestinal tract, skin, and hematological system were among the most frequent ADRs. For ADRs observed during admission predictors of its occurrence in a multivariate regression model were: OR (95% CI); more than 12 days' hospitalization: 2.11(1.27-3.47), any drug interaction: 9.33 (5.12-17) and acute change in estimated glomerular filtration rate over admission >20%: 2.46 (1.45-4.2). Worsening of renal function or drug interaction was observed in nine of the ten ADRs. Age, sex, nutrition, and number of drugs used were not related to ADRs. Conclusion A significant prevalence of ADRs was found among hospitalized patients. Duration of hospital admission, changes in renal status during hospitalization and drug interactions seem to be important risk factors for ADRs.
Introduction
Adverse drug reactions (ADRs) are a major cause of morbidity and pose a substantial burden on healthcare resources [1] . Detection of adverse drug reactions in hospitals provides an important measure of the burden of drug-related morbidity on the healthcare system. Epidemiological research shows an incidence of ADRs of 10-13% of all hospitalized patients [1] [2] [3] . These data remain clinically relevant because a significant proportion of ADRs are life-threatening and fatal ADRs rank fourth to sixth in the leading causes of death [4, 5] . Because up to 50% of ADRs are preventable, more attention to their detection and management is warranted [6, 7] .
Previous studies explored the magnitude, nature, and prevalence of ADRs. Common factors associated with ADRs are age, sex, number of drugs or comorbidities [5] [6] [7] [8] [9] [10] . Meanwhile, other important factors such as renal function or pharmacological counteractions have not been well studied [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Patients hospitalized in internal medicine wards have a predisposition for suffering ADRs because they are older, have several comorbidities, and need multiple drugs at hospitalization. Thus, patients hospitalized in internal medicine wards represent an interesting population for studying ADRs [11] . Frequently, these patients have renal insufficiency that can worsen during hospitalization because of the disease or condition that is causing the hospitalization. The different interactions between drugs could also be an important issue in the occurrence of ADRs [12] . Because of the complexity of treatments and the large number of drugs required, the clinician may not consider the interactions between drugs in daily practice. Recently, several software packages have been shown to be useful for analyzing drug prescription, which can be useful for predicting drug interactions, and, therefore, making it easier to adjust treatments [12, 13] .
The aim of this study was to describe the most common clinical manifestations and drugs frequently responsible for ADRs and to identify in patients who had ADRs while they were hospitalized in internal medicine independent factors predictive of these ADRs, including drug interactions and acute changes in renal function.
Patients and methods
This prospective observational study included all patients admitted to two general internal medicine wards of two docent hospitals, San Pedro de Alcantara (Cáceres) and La Paz (Madrid) in Spain, over a period of 10 consecutive weeks from 1 September 2009 to 14 November 2009. For detection and evaluation of potential ADRs all admissions underwent daily intensive pharmacovigilance by a minimum of three physicians (one staff physician and two residents in training).
Classification of adverse drug reactions
The classification proposed by Rawlins and Thompson [14] was used to establish the potential for predicting suspected adverse reactions. The algorithm of Naranjo and coworkers [15] was used to establish the causality between the drug and the suspected adverse reaction. An ADR was considered if it was definitive or probable. Data were collected using a specific data collection sheet developed for this investigation. For all patients, information regarding age, sex, weight and height, duration of hospital stay, and all diagnoses at discharge was collected, as well as amounts and brand names of medicines taken in the previous month, during the hospitalization, including self-medication. Blood tests for creatinine, ALT, AST, alkaline phosphatase, and glomerular filtration rate (estimated by the CockcroftGault formula: GFR (ml/min) = (140 − age (years)) × body weight (kg)/72 × serum creatinine (mg/dl); in females × 0.85) were determinate at entry and on the day of detection of ADRs. Patients were then classified into either Group 1 patients without ADR or Group 2 patients admitted because of an ADR or an ADR was detected during hospitalization.
The possible interactions between drugs were evaluated using Lexi-Interact™ Online (Lexi-Comp, Hudson, OH, USA) [16] . This is a comprehensive drug-to-drug interaction analysis program with a rapid indicator to show the interaction data. This program also assigned a risk rating of A, B, C, D, or X. The progression from A to X is accompanied by increased urgency in responding to the data. In general, A and B monographs are of academic, but not clinical concern. Monographs rated C, D, or X always requires the user's attention. The definition of each risk rating is as follows:
A No known interaction B No action needed: data demonstrate that the specified agents may interact with each other, but there is little to no evidence of clinical concern resulting from their concomitant use C Monitor therapy: data demonstrate that the specified agents may interact with each other in a clinically significant manner, the benefits of concomitant use of these two medications usually outweigh the risks, an appropriate monitoring plan should be implemented to identify potential negative effects, and dosage adjustments of one or both agents may be needed in a minority of patients D Consider therapy modification: data demonstrate that the two medications may interact with each other in a clinically significant manner, a patient-specific assessment must be conducted to determine whether the benefits of concomitant therapy outweigh the risks, specific actions must be taken in order to realize the benefits and/or minimize the toxicity resulting from concomitant use of the agents, and these actions may include aggressive monitoring, empiric dosage changes, and choosing alternative agents X Avoid combination: data demonstrate that the specified agents may interact with each other in a clinically significant manner, the risks associated with concomitant use of these agents usually outweigh the benefits, and these agents are generally considered contraindicated
The severity of ADRS was defined as: minor (effects would be considered tolerable, in most cases no need for medical intervention); moderate (medical intervention needed to treat effects, effects do not meet criteria for major); and major (effects may result in death, hospitalization, permanent injury, or therapeutic failure). We also collected information on the need to prolong hospitalization and the drug interaction itself as the cause of hospitalization.
Data analysis
All the data were expressed as the mean ± SD or a percentage. The differences in the values of the variables between the start and the end of the 10-week treatment period were calculated as percentage changes, values at the end of 12 weeks' treatment minus those at the start of the treatment × 100/the value at the start of the treatment. Patients who were hospitalized because of ADRs were excluded from the study of potential factors associated with ADRS. The Chi-squared test and Student's t test for independent samples were used to assess the statistical significance of differences between ratios and means respectively. In order to control potential confounding factors and to determine independent association between ADRS and risk factors for ADRS, the logistic regression analysis was employed. Factors demonstrating significant association with an ADR were included in the multivariate logistic regression model. Since other researchers had identified sex and age as risk factors for an ADR, these variables were included in the model without considering the statistical significance of the univariate analysis. A p value lower than 0.05 was considered statistically significant. Data analysis was performed using the SPSS software package (SPSS, Chicago, IL, USA).
Results
During a 10-week study period in two university hospitals, 405 patients were intensively monitored with respect to ADRs (Fig. 1 ). There were 128 adverse reactions in 126 (31%) patients. In 24 patients the ADRs was the cause of hospitalization and 102 patients suffered ADRs during hospitalization in an internal medicine ward. The ADRs were moderate in 93 (73%), major in 22 (17%), and were fatal in 2 patients (1.6%). Table 1 shows the main characteristics of patients in the study. There were no significant differences between the group of ADRs and non-ADRs in age, sex, and BMI. The number of diagnoses of each patient was larger in patients with ADRs: 2.3±1.2 vs 2.0±1.1. ADR patients have more lung diseases (35% vs 25%, p<0.05) and diabetes than controls (35% vs 20%, p<0.001). An important difference was the duration of hospitalization, which was longer for ADR patients: 18±17 days vs 9.6±5.8, p<0.001. Time from hospitalization to ADR was 4.3±3.9 days. Table 2 shows the drugs causing the different ADRs. Twenty-eight patients suffered from diarrhoea because of antibiotic use. The second most frequent ADR was bleeding, because of acenocoumarol or enoxaparin (15 patients). The third frequent ADR was rash (9 patients), although cutaneous involvement occurred in 20 patients, mainly due to some antibiotics, but also phenytoin and atorvastatin.
Among patients who had ADRs during admission (those hospitalized for this reason were excluded from analysis), factors associated with the occurrence of ADRs were analyzed and shown in Table 3 . Renal function and drug-drug interactions were statistically significant (p< 0.001). Elevated serum creatinine at hospitalization was significantly higher in patients with ADRs than in the control group during hospitalization (mg/dl): 2.02±1.22 vs 1.72±0.95. A glomerular filtration rate of below 60 ml/min Possible interactions between drugs were analyzed by an electronic device and were found in 84% of patients with ADRs vs 36% of controls (p<0.0001). Drugs causing interactions were metabolized mainly by cytochrome P 450 2C9 (drugs behave as inhibitors and substrates), 3A4 (inducers) and 2D6 (substrates). Interaction among three or more drugs appeared in 35% of ADR patients and 15% of controls (p<0.001). We judged the following to be causes of ADRs: 41 drug interactions, a decrease in renal function in 28 patients, and 17 with the possible influence of both. The drug interactions most likely involved were: in 21 patients cytochrome P 450 (2C9), 8 (3A4), 6 (2D6), 4 (1A2), 1 (2C9), and 1 (2C19).
In the logistic regression analysis to analyze factors associated with ADRs we found (as shown in Table 4 ): the duration of hospitalization (p<0.001), change of 20% in the glomerular filtration rate (p<0.001) ,and any drug interaction were associated with ADR (p<0.0001).
Discussion
The most common ADRs in hospitalized patients and associated factors were analyzed in this study. Postantibiotic diarrhea, bleeding due to antithrombotic therapy, and rash were the most frequent ADRs observed. Conditions associated with ADRs during hospitalization were prolonged hospitalization, acute change in glomerular filtration rate and drug interactions. Other previously cited risk factors, like age, sex, and number of drugs used, were not associated to ADRs in our study.
The frequency of ADRs in hospitals varies greatly between different published studies [2] [3] [4] , and can be explained by differences in their methods of identifying ADRs, the definition of adverse reactions, the methodology used for their detection, the complexity level of the pathologies under treatment, and the severity of the reaction, among others [5, 8, 9, 11, 12, [17] [18] [19] . The rate of ADRs found in this study-31%-was higher than the average of 6.7% (range 1.2-24%) found in previous studies [2] [3] [4] , but consistent with other reports [20, 21, 22] using, like us, the "gold standard of pharmacovigilance," intensive prospective ADR detection [20, 21] . Drugs causing ADRs [23] were similar to those described by other authors [16, 21, 23, 24] where cardiovascular drugs, anticoagulants and antibiotics were most frequently associated with ADRs. Reactions affecting the gastrointestinal tract, skin, mucosa, and hematological system were among the most frequently observed events. The ADRs are associated with drugs used frequently for managing disease of patients admitted to internal medicine wards.
Previous studies have examined many potential risk factors associated with ADRs in a variety of settings [5, 7, 10] . Conditions often cited as potential risk factors for ADRs are increasing age, sex, large numbers of prescribed drugs in individual patients or length of hospitalization [5] [6] [7] [8] [9] [10] . Failure of dose adjustment in patients with impaired renal function and drug-drug interactions were also considered important predictors of ADRs [10] [11] [12] . Studies in the field of pharmacovigilance using multiple regression models are rare and, we were unaware of the variables that were independent ADR predictors [20] . There is consensus regarding the predictive power of large numbers of prescribed drugs-more than four-as an independent predictor of ADRs [6, 8, 20] . In our analysis, the number of drug interactions was one of the most important factors associated with the occurrence of ADRs, but not the number of drugs itself. We found a high rate of medication use with interaction by cytochrome P450 2C9, 2D6, and 3A4. These cytochrome are frequently implicated in the metabolism of common drugs [25] . Nowadays, the complexity of treatments make it difficult to know the possibility of the occurrence of interactions between two or more drugs; thus, an adequate software package [25] [26] [27] is useful. Most studies surmised that 69% of adverse events are preventable [7, 23] and can therefore be considered to result from medication errors. Although there are several recommendations about using electronic devices, their use has not been generalized and electronic devices have resulted in several problems that have to be solved [25, 27] . We suggest checking drug interactions on a software package, or assessing the cytochrome involved in the metabolism of drugs frequently. Another common problem that has not been previously well studied is renal function as a cause of ADRs [27, 28, 29, 30] . We report an elevated incidence of renal dysfunction measured as having a glomerular filtration rate below 60 ml/min, 41% in ADRs patients vs 22% in controls. Also, we observed a worsening of renal function during hospitalization, a drop in renal function >20% in 35% of cases vs 18% of controls. This important prevalence of renal impairment was clearly different from that reported by others [27] . Dose adjustment with renal function probably would have prevented the occurrence of several ADRs, although we were able to observe ADRs before identifying the changes in renal function, and prevent dose titration. Sex, age, and malnutrition also correlated with the presence of ADRs in reports published in the literature [5] [6] [7] [8] [9] [10] . However, in our population, albumin, sex and increasing age were not independent ADR predictors. In summary, acute changes in renal function or drug interactions were observed in 88% of patients suffering ADRs. Therefore, we suggest that drug dose adjustment for renal function and assessment of interactions could prevent a large number of ADRs in clinical practice.
In terms of pharmacoeconomy, it was calculated that the cost of hospitalization of patients with ADRs could be about $2,000 million per year in the United States [30] . It is estimated that for patients who had an adverse drug reaction, the duration of hospitalization was prolonged by 4.3 days compared with patients who did not experience an adverse drug reaction, leading to an increase in costs for each hospital stay. In the present study, length of hospitalization was greater for patients with ADRs (18 vs 9.6 days). We were unable to analyze whether or not a longer duration was the cause or the consequence of ADRs. However, the fact that ADRs appeared on the 5th day of hospitalization in most cases shows that ADRs can be one of the main causes of a longer duration hospitalization for ADR patients.
The study has some limitations. Probably the most important is the fact that we were unable to analyze specifically the factor implicated in ADRs in each particular case. Despite using a multiple regression model, a definitive discrimination between causative or confounding factors in predicting an ADR is difficult. We were unable to judge whether or not renal failure was the cause or effect of ADRs in all situations. Also, we only analyzed pharmacokinetic and not pharmacodynamic interactions because of the program used. However, renal insufficiency or drug interactions were implicated in 9 out of 10 ADRs, so we have to consider these two mechanisms as very important factors contributing to ADR development. Studies with a longer period of observation and more hospitals included in the study of ADRs would help to determine the significance of these mechanisms in ADRs or to identify more factors implicated.
In conclusion, we believe that the present study makes important contributions. First, the real incidence of ADRs in internal medicine could have been underestimated. Second, acute renal function worsening during hospitalization, prior renal dysfunction, and drug interactions seem to be important factors contributing to ADR occurrence.
